APA (7th ed.) Citation

Bonnet, F., Chen, H., Cooper, A., Gomes, M. B., Ji, L., Leigh, P., . . . Khunti, K. (2021). What are the factors associated with long‐term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second‐line therapy? Results from the DISCOVER study. Diabetes, Obesity & Metabolism, 23(10), 2336. https://doi.org/10.1111/dom.14476

Chicago Style (17th ed.) Citation

Bonnet, Fabrice, et al. "What Are the Factors Associated with Long‐term Glycaemic Control in Patients with Type 2 Diabetes and Elevated Glycated Haemoglobin (≥7.0%) at Initiation of Second‐line Therapy? Results from the DISCOVER Study." Diabetes, Obesity & Metabolism 23, no. 10 (2021): 2336. https://doi.org/10.1111/dom.14476.

MLA (9th ed.) Citation

Bonnet, Fabrice, et al. "What Are the Factors Associated with Long‐term Glycaemic Control in Patients with Type 2 Diabetes and Elevated Glycated Haemoglobin (≥7.0%) at Initiation of Second‐line Therapy? Results from the DISCOVER Study." Diabetes, Obesity & Metabolism, vol. 23, no. 10, 2021, p. 2336, https://doi.org/10.1111/dom.14476.